PHILADELPHIA, Pennysylvania and DUBLIN, Ireland, October 29 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights

- Product sales up 31% to $713 million - Product sales excluding ADDERALL XR(R) up 51% to $444 million - New product sales(1) $276 million, 39% of product sales (2007: 22%) - Total revenues up 28% to $779 million - Non GAAP earnings(2) per ADS up 88% to $1.17 (2007: $0.62) - US GAAP earnings(2) per ADS down 62% to $0.07 (2007: $0.19)

(1) New product sales comprise DAYTRANA(R), ELAPRASE(R), FIRAZYR(R), FOSRENOL(R), LIALDA(R) / MEZAVANT(R) and VYVANSE(R)

(2) Earnings from continuing operations

HOPSTEN, Germany, October 29 /PRNewswire/ --

- 'Top Hotel Star Award 2008' for plasmaNorm Technology

What can it do - this air treatment system that Germany's top catering professionals named 'Innovation of the year, 2008'? plasmaNorm, the internationally patented air cleansing system, sets a new standard with state-of-the-technology performance. Air passed through the filter is completely free of odours and germs - the once-and-for-all solution for large kitchens. Fire protection is built-in, as no deposits collect in the system. plasmaNorm air treatment systems are available for cooker hoods and indoor air filters, kitchen extractor fans and circulating air systems.

GENEVA, Switzerland, October 29 /PRNewswire/ --

- Merck Serono's US Affiliate EMD Serono, Inc. to Acquire Rights in Tesamorelin, a Phase 3 Compound Being Investigated for the Treatment of Excess Abdominal Fat in HIV Patients With Lipodystrophy in the US

- Merck KGaA, Darmstadt, Germany, of Which Merck Serono is a Division, to Make an Equity Investment in Theratechnologies

SARASOTA, Florida, October 29 /PRNewswire/ --

CPC of America, Inc. (OTC Bulletin Board: CPCF), a company focused on the development of therapeutic devices for use in endovascular procedures, today announced that it is implementing a European strategy for the development and distribution of its MedClose(TM) investigational-stage medical device. In the roll out of its strategy, CPC announced an agreement with Medical Product Service GmbH (MPS) of Germany to act as authorized European representative for the Company in seeking European regulatory approval for MedClose(TM) Vascular Closure Device (VCD). MedClose(TM) is an extravascular puncture-closure device intended to be used with a biological sealant for diagnostic and interventional cardiovascular procedures.

LONDON, October 29 /PRNewswire/ -- An immediate re-opening of talks on a substantial pay increase for NHS staff has been called for by Unite, the largest union in the country, in its own evidence to the Pay Review Body (PRB).

Unite, which this week started balloting its members on taking industrial action, including strike action, has always respected the independence of the PRB from ministerial interference.

Unite National Officer for Health, Karen Reay said: It is entirely logical that Unite should be submitting its own PRB evidence, while at the same time canvassing its members for industrial action over the derisory three-year pay deal imposed by the government, contrary to the PRB's recommendation for this year.

REHOVOT, Israel; JERSEY CITY, New Jersey, October 29 /PRNewswire/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics, announced today its management will present at Oppenheimer 19th Annual Healthcare Conference taking place November 3-4, 2008 at the Waldorf-Astoria Hotel in New York City.

About MicroRNA